Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Russell-Jones

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Diabetes Care|February 22, 2018
Response to Comment on Russell-Jones et al. Diabetes Care 2017;40:943-950. Comment on Bowering et al. Diabetes Care 2017;40:951-957Bruce W Bode, Keith Bowering, David Russell-Jones
Annals of Medicine|June 29, 2021
Leveraging advances in diabetes technologies in primary care: a narrative reviewBruce Bode, Aaron King, David Russell-Jones, et al.
Journal of Critical Care|February 3, 2020
A potential diagnostic problem on the ICU: Euglycaemic diabetic Ketoacidosis associated with SGLT2 inhibitionIdrisu Sanusi, Alexander Sarnowski, David Russell-Jones, et al.
Clinical Therapeutics|June 29, 2004
Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimenDavid Russell-Jones, Richard Simpson, Birgitte Hylleberg, et al.
The Lancet. Diabetes & Endocrinology|May 31, 2015
SGLT inhibition and euglycaemic diabetic ketoacidosisJulia Hine, Heather Paterson, Esha Abrol, et al.
Clinical Medicine (London, England)|June 14, 2013
Assisted feeding for elderly inpatientsJacqueline Gilbert, Amber Appleton, John Jerrim, et al.
Metabolism: Clinical and Experimental|September 19, 2012
Effects of three weeks of mild sleep restriction implemented in the home environment on multiple metabolic and endocrine markers in healthy young menM Denise Robertson, David Russell-Jones, A Margot Umpleby, et al.
The Lancet. Diabetes & Endocrinology|May 28, 2018
Novel diabetes subgroupsMichael D Feher, Neil Munro, David Russell-Jones, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 29, 2024
Frequency of hypoglycaemia with basal insulin treatments in adults with type 1 diabetes treated with basal-bolus insulin regimens in treat-to-target trials: A narrative reviewDavid Russell-Jones, Timothy S Bailey, Wendy Lane, et al.
The European Respiratory Journal|December 11, 2020
Intrapulmonary shunt measured by bedside pulse oximetry predicts worse outcomes in severe COVID-19Aleksandra Kotwica, Harry Knights, Nikhil Mayor, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Diabetes Care|February 22, 2018
Response to Comment on Russell-Jones et al. Diabetes Care 2017;40:943-950. Comment on Bowering et al. Diabetes Care 2017;40:951-957Bruce W Bode, Keith Bowering, David Russell-Jones
Annals of Medicine|June 29, 2021
Leveraging advances in diabetes technologies in primary care: a narrative reviewBruce Bode, Aaron King, David Russell-Jones, et al.
Journal of Critical Care|February 3, 2020
A potential diagnostic problem on the ICU: Euglycaemic diabetic Ketoacidosis associated with SGLT2 inhibitionIdrisu Sanusi, Alexander Sarnowski, David Russell-Jones, et al.
Clinical Therapeutics|June 29, 2004
Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimenDavid Russell-Jones, Richard Simpson, Birgitte Hylleberg, et al.
The Lancet. Diabetes & Endocrinology|May 31, 2015
SGLT inhibition and euglycaemic diabetic ketoacidosisJulia Hine, Heather Paterson, Esha Abrol, et al.
Clinical Medicine (London, England)|June 14, 2013
Assisted feeding for elderly inpatientsJacqueline Gilbert, Amber Appleton, John Jerrim, et al.
Metabolism: Clinical and Experimental|September 19, 2012
Effects of three weeks of mild sleep restriction implemented in the home environment on multiple metabolic and endocrine markers in healthy young menM Denise Robertson, David Russell-Jones, A Margot Umpleby, et al.
The Lancet. Diabetes & Endocrinology|May 28, 2018
Novel diabetes subgroupsMichael D Feher, Neil Munro, David Russell-Jones, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 29, 2024
Frequency of hypoglycaemia with basal insulin treatments in adults with type 1 diabetes treated with basal-bolus insulin regimens in treat-to-target trials: A narrative reviewDavid Russell-Jones, Timothy S Bailey, Wendy Lane, et al.
The European Respiratory Journal|December 11, 2020
Intrapulmonary shunt measured by bedside pulse oximetry predicts worse outcomes in severe COVID-19Aleksandra Kotwica, Harry Knights, Nikhil Mayor, et al.
Pageof 6